当前位置:首页 - 行情中心 - 心脉医疗(688016) - 财务分析 - 现金流量表

心脉医疗

(688016)

  

流通市值:127.79亿  总市值:127.79亿
流通股本:1.23亿   总股本:1.23亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金245,121,060.341,369,647,675.84854,974,998.51607,420,761.94
  收到的税费返还-501,911.56999,420.29501,911.56
  收到其他与经营活动有关的现金2,343,741.5884,787,483.59105,822,276.481,284,158.21
  经营活动现金流入小计247,464,801.921,454,937,070.99961,796,695.2689,206,831.71
  购买商品、接受劳务支付的现金74,389,722.11284,442,393.51143,784,792.1190,445,596.42
  支付给职工以及为职工支付的现金77,022,849.17283,610,959.65202,134,285.92131,979,768.56
  支付的各项税费42,619,371.92178,954,504.5151,959,022.8988,304,922.07
  支付其他与经营活动有关的现金42,750,736.63134,865,258.08100,716,945.9259,873,223.46
  经营活动现金流出小计236,782,679.83881,873,115.74598,595,046.84370,603,510.51
  经营活动产生的现金流量净额10,682,122.09573,063,955.25363,201,648.36318,603,321.2
二、投资活动产生的现金流量:
  收回投资收到的现金750,000,0004,930,000,0002,925,000,0002,135,000,000
  取得投资收益收到的现金1,211,896.1215,976,849.839,168,253.086,974,089.84
  处置固定资产、无形资产和其他长期资产收回的现金净额18,000---
  投资活动现金流入小计751,229,896.124,945,976,849.832,934,168,253.082,141,974,089.84
  购建固定资产、无形资产和其他长期资产支付的现金29,152,851.47303,033,026.27215,020,875.92128,993,857.06
  投资支付的现金1,640,000,0005,030,000,0004,090,000,0002,525,000,000
  投资活动现金流出小计1,669,152,851.475,333,033,026.274,305,020,875.922,653,993,857.06
  投资活动产生的现金流量净额-917,922,955.35-387,056,176.44-1,370,852,622.84-512,019,767.22
三、筹资活动产生的现金流量:
  取得借款收到的现金-126,000,000126,000,000126,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-126,000,000126,000,000126,000,000
  偿还债务支付的现金-140,000,000140,000,000140,000,000
  分配股利、利润或偿付利息支付的现金-201,834,960.143,558,034.843,558,034.8
  支付其他与筹资活动有关的现金3,051,198.59134,083,628.72122,755,433.4485,804,482.2
  筹资活动现金流出小计3,051,198.59475,918,588.82306,313,468.24269,362,517
  筹资活动产生的现金流量净额-3,051,198.59-349,918,588.82-180,313,468.24-143,362,517
四、汇率变动对现金及现金等价物的影响-3,946,951.74-2,871,180.32255,712.02890,545.98
五、现金及现金等价物净增加额-914,238,983.59-166,781,990.33-1,187,708,730.7-335,888,417.04
  加:期初现金及现金等价物余额1,892,049,254.812,058,831,245.142,058,831,245.142,058,831,245.14
  期末现金及现金等价物余额977,810,271.221,892,049,254.81871,122,514.441,722,942,828.1
补充资料:
  净利润-554,659,959.66-310,624,892.41
  资产减值准备-9,271,248.76-3,850,457.37
  固定资产和投资性房地产折旧-13,593,988.86-7,468,090.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,593,988.86-7,468,090.14
  无形资产摊销-53,408,929.34-24,281,615.02
  长期待摊费用摊销-10,651,037.81-5,443,237.27
  处置固定资产、无形资产和其他长期资产的损失---3,956.26
  固定资产报废损失-89,021--
  公允价值变动损失--367,945.21--
  财务费用-6,882,102.44-1,647,252.81
  投资损失--15,976,849.83--7,659,856.97
  递延所得税--11,348,913.81--74,456.82
  其中:递延所得税资产减少--5,372,460.42--3,278,274.31
    递延所得税负债增加--5,976,453.39-3,203,817.49
  存货的减少--14,369,865.11-45,949,631.38
  经营性应收项目的减少-90,927,824.01--159,226,028.01
  经营性应付项目的增加--159,007,774.59-65,634,222.31
  其他-14,287,357.8-8,236,070.76
  不涉及现金收支的投资和筹资活动金额其他项目-1,220,071.08--
  现金的期末余额-1,892,049,254.81-1,722,942,828.1
  减:现金的期初余额-2,058,831,245.14-2,058,831,245.14
  现金及现金等价物的净增加额--166,781,990.33--335,888,417.04
公告日期2026-04-302026-03-312025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑